Mechanisms of immunotherapy: A historical perspective

Annals of Allergy, Asthma and Immunology

Volumn 105, Issue 5, 2010, Pages 340-347

  Shakir, Ebrahim M ^a   Cheung, Dorothy S ^a   Grayson, Mitchell H ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRASS POLLEN EXTRACT; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G4; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; TRANSCRIPTION FACTOR GATA 3;

ALLERGIC REACTION; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; EFFECTOR CELL; HELPER CELL; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOTHERAPY; MEDLINE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL;

ALLERGENS; ANIMALS; ANTIBODIES, BLOCKING; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; HYPERSENSITIVITY; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; IMMUNIZATION; IMMUNOGLOBULIN E; IMMUNOTHERAPY; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 78049469558     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2010.09.012     Document Type: Review

References (83)

1. S.R. Durham, S.M. Walker, and E.M. Varga Long-term clinical efficacy of grass-pollen immunotherapy N Engl J Med. 341 1999 468 475
2. A.J. Frew Immunotherapy of allergic disease J Allergy Clin Immunol. 111 2003 S712 S719
3. M. Jackson Allergy: The History of a Modern Malady 2006 Reaktion Books London, England
4. L. Noon Prophylactic inoculation against hay fever Lancet 177 1911 1572 1573
5. J. Freeman Further observations on the treatment of hay fever by hypodermic inoculations of pollen vaccine Lancet 178 1911 814 817
6. R. Cooke Hay fever and asthma: the uses and limitations of desensitization N Y Med J 107 1918 577 583
7. A. Besredka Of anaphylaxis, of antianaphylaxis against horse serum, and the mechanism of antianaphylaxis Ann Inst Pasteur. 21 1907 384 391
8. C. Prausnitz, and H. Kustner Studies on supersensitivity Centralbl Bakteriol. 86 1921 160
9. R.A. Cooke, J.H. Barnard, S. Hebald, and A. Stull Serological evidence of immunity with coexisting sensitization in a type of human allergy (hay fever) J Exp Med. 62 1935 733 750
10. M.H. Loveless Immunological studies of pollinosis, I: the presence of two antibodies related to the same pollen-antigen in the serum of treated hay-fever patients J Immunol. 38 1940 25 50
11. M.H. Loveless Immunological studies of pollinosis, IV: the relationship between thermostable antibody in the circulation and clinical immunity J Immunol. 47 1943 165 180
12. M.A. Scully Studies on the blocking antibody of Cooke in the treatment of hay fever J Allergy 12 1941 549 558
13. J.J. Pruzansky, and R. Patterson Histamine release from leukocytes of hypersensitive individuals, I: use of several antigens J Allergy 38 1966 315 320
14. P.S. Norman Immunotherapy: past and present J Allergy Clin Immunol. 102 1998 1 10
15. P.P. Van Arsdel Jr, and E. Middleton Jr The effect of hyposensitization on the in vitro histamine release by specific antigen J Allergy 32 1961 348 356
16. L.M. Lichtenstein, and A.G. Osler Studies on the mechanisms of hypersensitivity phenomena, XII: an in vitro study of the reaction between ragweed pollen antigen, allergic human serum and ragweed-sensitive human leukocytes J Immunol. 96 1966 169 179
17. K. Ishizaka, and T. Ishizaka Identification of {gamma}E-antibodies as a carrier of reaginic activity J Immunol. 99 1967 1187 1198
18. D.A. Levy, and A. Osler Studies on the mechanism of hypersensitivity phenomena, XVI: in vitro assays of reaginic activity in human sera: effect of therapeutic immunization on seasonal titer changes J Immunol. 99 1967 1068 1077
19. P. Levine, and A.F. Coca Studies in hypersensitiveness, XXII: on the nature of the alleviating effect of the specific treatment of atopic conditions J Immunol. 11 1926 449 464
20. G.C. Yunginger JW Seasonal changes in IgE antibodies and their relationship tp the IgG antibodies during immunotherapy for ragweed hay fever J Clin Invest. 52 1973 1268 1275
21. L.M. Lichtenstein, K. Ishizaka, P.S. Norman, A.K. Sobotka, and B.M. Hill IgE antibody measurements in ragweed hay fever: relationship to clinical severity and the results of immunotherapy J Clin Invest. 52 1973 472 482
22. M. van der Giessen, W.L. Homan, G. van Kernbeek, R.C. Aalberse, and P.H. Dieges Subclass typing of IgG antibodies formed by grass pollen-allergic patients during immunotherapy Int Arch Allergy Appl Immunol. 50 1976 625 640
23. B.E. Garcia, M.L. Sanz, J.J. Gato, J. Fernandez, and A. Oehling IgG4 blocking effect on the release of antigen-specific histamine J Investig Allergol Clin Immunol. 3 1993 26 33
24. V. Visco, C. Dolecek, and S. Denepoux Human IgG monoclonal antibodies that modulate the binding of specific IgE to birch pollen Bet v 1 J Immunol. 157 1996 956 962
25. L.K. Pierson-Mullany, D. Jackola, M. Blumenthal, and A. Rosenberg Altered allergen binding capacities of Amb a 1-specific IgE and IgG4 from ragweed-sensitive patients receiving immunotherapy Ann Allergy Asthma Immunol. 84 2000 241 243
26. R.J. van Neerven, T. Wikborg, and G. Lund Blocking antibodies induced by specific allergy vaccination prevent the activation of CD4+ T cells by inhibiting serum-IgE-facilitated allergen presentation J Immunol. 163 1999 2944 2952
27. A.M. Bentley, M.R. Jacobson, and V. Cumberworth Immunohistology of the nasal mucosa in seasonal allergic rhinitis: increases in activated eosinophils and epithelial mast cells J Allergy Clin Immunol. 89 1992 877 883
28. E. Gomez, J.E. Clague, D. Gatland, and R.J. Davies Effect of topical corticosteroids on seasonally induced increases in nasal mast cells Br Med J (Clin Res Ed) 296 1988 1572 1573
29. H. Otsuka, A. Mezawa, M. Ohnishi, K. Okubo, H. Seki, and M. Okuda Changes in nasal metachromatic cells during allergen immunotherapy Clin Exp Allergy 21 1991 115 119
30. P.S. Creticos, N.F. Adkinson Jr, and A. Kagey-Sobotka Nasal challenge with ragweed pollen in hay fever patients Effect of immunotherapy J Clin Invest. 76 1985 2247 2253
31. J. Bousquet, H.J. Maasch, and A. Hejjaoui Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids, III: efficacy and safety of unfractionated and high-molecular-weight preparations in rhinoconjunctivitis and asthma J Allergy Clin Immunol. 84 1989 546 556
32. M.J. Furin, P.S. Norman, and P.S. Creticos Immunotherapy decreases antigen-induced eosinophil cell migration into the nasal cavity J Allergy Clin Immunol. 88 1991 27 32
33. V.A. Varney, Q.A. Hamid, and M. Gaga Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses J Clin Invest. 92 1993 644 651
34. J.A. Warner, M.M. Pienkowski, M. Plaut, P.S. Norman, and L.M. Lichtenstein Identification of histamine releasing factor(s) in the late phase of cutaneous IgE-mediated reactions J Immunol. 136 1986 2583 2587
35. S.M. MacDonald, T. Rafnar, J. Langdon, and L.M. Lichtenstein Molecular identification of an IgE-dependent histamine-releasing factor Science 269 1995 688 690
36. C. Brunet, P.M. Bedard, A. Lavoie, M. Jobin, and J. Hebert Allergic rhinitis to ragweed pollen, II: modulation of histamine-releasing factor production by specific immunotherapy J Allergy Clin Immunol. 89 1992 87 94
37. P. Kuna, R. Alam, B. Kuzminska, and J. Rozniecki The effect of preseasonal immunotherapy on the production of histamine-releasing factor (HRF) by mononuclear cells from patients with seasonal asthma: results of a double-blind, placebo-controlled, randomized study J Allergy Clin Immunol. 83 1989 816 824
38. T.N. Liao, and K.H. Hsieh Altered production of histamine-releasing factor (HRF) activity and responsiveness to HRF after immunotherapy in children with asthma J Allergy Clin Immunol. 86 1990 894 901
39. T.R. Mosmann, H. Cherwinski, M.W. Bond, M.A. Giedlin, and R.L. Coffman Two types of murine helper T cell clone. I Definition according to profiles of lymphokine activities and secreted proteins J Immunol. 136 1986 2348 2357
40. D.A. Lebman, and R.L. Coffman Interleukin 4 causes isotype switching to IgE in T cell-stimulated clonal B cell cultures J Exp Med. 168 1988 853 862
41. J.A. Denburg Bone marrow in atopy and asthma: hematopoietic mechanisms in allergic inflammation Immunol Today 20 1999 111 113
42. Z. Zhu, R.J. Homer, and Z. Wang Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production J Clin Invest. 103 1999 779 788
43. S.R. Durham, S. Ying, and V.A. Varney Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-gamma J Allergy Clin Immunol. 97 1996 1356 1365
44. Q.A. Hamid, E. Schotman, M.R. Jacobson, S.M. Walker, and S.R. Durham Increases in IL-12 messenger RNA+ cells accompany inhibition of allergen-induced late skin responses after successful grass pollen immunotherapy J Allergy Clin Immunol. 99 1997 254 260
45. H. Secrist, R.H. DeKruyff, and D.T. Umetsu Interleukin 4 production by CD4+ T cells from allergic individuals is modulated by antigen concentration and antigen-presenting cell type J Exp Med. 181 1995 1081 1089
46. L.A. Herzenberg, E.L. Chan, M.M. Ravitch, and R.J. Riblet Active suppression of immunoglobulin allotype synthesis, 3: identification of T cells as responsible for suppression by cells from spleen, thymus, lymph node, and bone marrow J Exp Med. 137 1973 1311 1324
47. C.L. Bennett, J. Christie, and F. Ramsdell The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 Nat Genet. 27 2001 20 21
48. S. Hori, T. Nomura, and S. Sakaguchi Control of regulatory T cell development by the transcription factor Foxp3 Science 299 2003 1057 1061
49. H. Groux, A. O'Garra, and M. Bigler A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis Nature 389 1997 737 742
50. W. Chen, W. Jin, and N. Hardegen Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3 J Exp Med. 198 2003 1875 1886
51. H. Fukaura, S.C. Kent, M.J. Pietrusewicz, S.J. Khoury, H.L. Weiner, and D.A. Hafler Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients J Clin Invest. 98 1996 70 77
52. M.G. Roncarolo, S. Gregori, M. Battaglia, R. Bacchetta, K. Fleischhauer, and M.K. Levings Interleukin-10-secreting type 1 regulatory T cells in rodents and humans Immunol Rev. 212 2006 28 50
53. A.M. Faria, and H.L. Weiner Oral tolerance Immunol Rev. 206 2005 232 259
54. L. Mayer, and L. Shao Therapeutic potential of oral tolerance Nat Rev Immunol. 4 2004 407 419
55. L.M. Santos, A. al-Sabbagh, A. Londono, and H.L. Weiner Oral tolerance to myelin basic protein induces regulatory TGF-beta-secreting T cells in Peyers patches of SJL mice Cell Immunol. 157 1994 439 447
56. R.E. Rocklin, A.L. Sheffer, D.K. Greineder, and K.L. Melmon Generation of antigen-specific suppressor cells during allergy desensitization N Engl J Med. 302 1980 1213 1219
57. I. Bellinghausen, G. Metz, A.H. Enk, S. Christmann, J. Knop, and J. Saloga Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects Eur J Immunol. 27 1997 1131 1139
58. P. Jeannin, S. Lecoanet, Y. Delneste, J.F. Gauchat, and J.Y. Bonnefoy IgE versus IgG4 production can be differentially regulated by IL-10 J Immunol. 160 1998 3555 3561
59. B. Royer, S. Varadaradjalou, P. Saas, J.J. Guillosson, J.P. Kantelip, and M. Arock Inhibition of IgE-induced activation of human mast cells by IL-10 Clin Exp Allergy 31 2001 694 704
60. M. Jutel, M. Akdis, and F. Budak IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy Eur J Immunol. 33 2003 1205 1214
61. C.A. Akdis, M. Akdis, and T. Blesken Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro J Clin Invest. 98 1996 1676 1683
62. C. Ebner, U. Siemann, and B. Bohle Immunological changes during specific immunotherapy of grass pollen allergy: reduced lymphoproliferative responses to allergen and shift from TH2 to TH1 in T-cell clones specific for Phl p 1, a major grass pollen allergen Clin Exp Allergy 27 1997 1007 1015
63. M. Akdis, J. Verhagen, and A. Taylor Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells J Exp Med. 199 2004 1567 1575
64. C.A. Akdis, A. Joss, M. Akdis, A. Faith, and K. Blaser A molecular basis for T cell suppression by IL-10: CD28-associated IL-10 receptor inhibits CD28 tyrosine phosphorylation and phosphatidylinositol 3-kinase binding FASEB J 14 2000 1666 1668
65. F. Meiler, J. Zumkehr, S. Klunker, B. Ruckert, C.A. Akdis, and M. Akdis In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure J Exp Med. 205 2008 2887 2898
66. K. Wing, Y. Onishi, and P. Prieto-Martin CTLA-4 control over Foxp3+ regulatory T cell function Science 322 2008 271 275
67. O. Akbari, R.H. DeKruyff, and D.T. Umetsu Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen Nat Immunol. 2 2001 725 731
68. D.H. Munn, M.D. Sharma, and J.R. Lee Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase Science 297 2002 1867 1870
69. A. Mazzoni, H.A. Young, J.H. Spitzer, A. Visintin, and D.M. Segal Histamine regulates cytokine production in maturing dendritic cells, resulting in altered T cell polarization J Clin Invest. 108 2001 1865 1873
70. P. Johansen, G. Senti, J. Maria Martinez Gomez, and T.M. Kundig Medication with antihistamines impairs allergen-specific immunotherapy in mice Clin Exp Allergy 38 2008 512 519
71. C. Mauri, D. Gray, N. Mushtaq, and M. Londei Prevention of arthritis by interleukin 10-producing B cells J Exp Med. 197 2003 489 501
72. G. Deniz, G. Erten, and U.C. Kucuksezer Regulatory NK cells suppress antigen-specific T cell responses J Immunol. 180 2008 850 857
73. J.P. Edwards, X. Zhang, K.A. Frauwirth, and D.M. Mosser Biochemical and functional characterization of three activated macrophage populations J Leukoc Biol. 80 2006 1298 1307
74. C. Mauri, and N. Carter Is there a feudal hierarchy amongst regulatory immune cells? more than just Tregs Arthritis Res Ther. 11 2009 237
75. T.B. Casale Omalizumab: an effective anti-IgE treatment for allergic asthma and rhinitis Drugs Today (Barc) 40 2004 367 376
76. S.T. Holgate, R. Djukanovic, T. Casale, and J. Bousquet Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy Clin Exp Allergy 35 2005 408 416
77. T.B. Casale, W.W. Busse, and J.N. Kline Omalizumab pretreatment decreases acute reactions after rush immunotherapy for ragweed-induced seasonal allergic rhinitis J Allergy Clin Immunol. 117 2006 134 140
78. J. Kuehr, J. Brauburger, and S. Zielen Efficacy of combination treatment with anti-IgE plus specific immunotherapy in polysensitized children and adolescents with seasonal allergic rhinitis J Allergy Clin Immunol. 109 2002 274 280
79. J. Kildsgaard, J. Brimnes, H. Jacobi, and K. Lund Sublingual immunotherapy in sensitized mice Ann Allergy Asthma Immunol. 98 2007 366 372
80. H.Q. Yu, X.H. Li, and H. Guo Sublingual immunotherapy efficacy of Dermatophagoides farinae vaccine in a murine asthma model Int Arch Allergy Immunol. 152 2010 41 48
81. J.D. Campbell, K.F. Buckland, and S.J. McMillan Peptide immunotherapy in allergic asthma generates IL-10-dependent immunological tolerance associated with linked epitope suppression J Exp Med. 206 2009 1535 1547
82. T.M. Kundig, G. Senti, and G. Schnetzler Der p 1 peptide on virus-like particles is safe and highly immunogenic in healthy adults J Allergy Clin Immunol. 117 2006 1470 1476
83. P.S. Creticos, J.T. Schroeder, and R.G. Hamilton Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis N Engl J Med. 355 2006 1445 1455